Clinical trial: Addition of atezolizumab to standard care does not improve limited-stage small cell lung cancer survival

by NRG OncologyCredit: Unsplash/CC0 Public DomainThe addition of the cancer immunotherapy drug atezolizumab to the standard of care concurrent chemoradiation (cCRT) did not improve overall survival fo

Updated on: October 21,2024 0

Clinical trial: Addition of atezolizumab to standard care does not improve limited-stage small cell lung cancer survival

by NRG OncologyCredit: Unsplash/CC0 Public DomainThe addition of the cancer immunotherapy drug atezolizumab to the standard of care concurrent chemoradiation (cCRT) did not improve overall survival fo

Updated on:October 21,2024 0

Race, insurance status linked to job loss after breast cancer

by Neil Schoenherr,Washington University in St. LouisCredit: Washington University in St. LouisJob loss following early-stage breast cancer diagnosis is associated with race and insurance status

Updated on: April 07,2024 16

Race, insurance status linked to job loss after breast cancer

by Neil Schoenherr,Washington University in St. LouisCredit: Washington University in St. LouisJob loss following early-stage breast cancer diagnosis is associated with race and insurance status

Updated on:April 07,2024 16

Maternal obesity may promote liver cancer

by University of GenevaCredit:JHEP Reports(2024). DOI: 10.1016/j.jhepr.2024.101056Obesity, which could reach 50% of the population in certain developed countries by 2030, is a major p

Updated on: March 20,2024 16

Maternal obesity may promote liver cancer

by University of GenevaCredit:JHEP Reports(2024). DOI: 10.1016/j.jhepr.2024.101056Obesity, which could reach 50% of the population in certain developed countries by 2030, is a major p

Updated on:March 20,2024 16

A new therapeutic strategy to improve treatment of aggressive endometrial cancer

by Autonomous University of BarcelonaERK5 inhibition impairs EC cell proliferation.AGenomic profiles of components of the MEK5-ERK5 pathway in EC patients obtained from Uterine Corpus

Updated on: February 23,2024 15

A new therapeutic strategy to improve treatment of aggressive endometrial cancer

by Autonomous University of BarcelonaERK5 inhibition impairs EC cell proliferation.AGenomic profiles of components of the MEK5-ERK5 pathway in EC patients obtained from Uterine Corpus

Updated on:February 23,2024 15

Enzyme that helps protect us from stress linked to liver cancer growth

by Medical College of Georgia at Augusta UniversityDr. Satya Ande, molecular biologist in the MCG Department of Biochemistry and Molecular Biology and Georgia Cancer Center and MCG postdoctoral f

Updated on: April 14,2024 10

Enzyme that helps protect us from stress linked to liver cancer growth

by Medical College of Georgia at Augusta UniversityDr. Satya Ande, molecular biologist in the MCG Department of Biochemistry and Molecular Biology and Georgia Cancer Center and MCG postdoctoral f

Updated on:April 14,2024 10

Researchers unravel novel mechanism by which tumors grow resistant to radiotherapy

by Ludwig Institute for Cancer ResearchRalph Weichselbaum is the co-director of the Ludwig Center at Chicago. Credit: Ludwig Cancer ResearchA Ludwig Cancer Research study has uncovered a key mech

Updated on: March 12,2024 19

Researchers unravel novel mechanism by which tumors grow resistant to radiotherapy

by Ludwig Institute for Cancer ResearchRalph Weichselbaum is the co-director of the Ludwig Center at Chicago. Credit: Ludwig Cancer ResearchA Ludwig Cancer Research study has uncovered a key mech

Updated on:March 12,2024 19

Long-term study finds faster breast cancer radiation treatment as effective as long course

by McMaster UniversityTimothy Whelan is a professor of oncology at McMaster University and a radiation oncologist at the Juravinski Cancer Centre of Hamilton Health Sciences. He holds a Canada Re

Updated on: April 18,2024 20

Long-term study finds faster breast cancer radiation treatment as effective as long course

by McMaster UniversityTimothy Whelan is a professor of oncology at McMaster University and a radiation oncologist at the Juravinski Cancer Centre of Hamilton Health Sciences. He holds a Canada Re

Updated on:April 18,2024 20

Cancer survivors predicted to number over 22 million by 2030

by American Cancer SocietyCredit: CC0 Public DomainThere were more than 16.9 million Americans with a history of cancer on January 1, 2019, a number that is projected to reach more than 22.1 mill

Updated on: March 06,2024 20

Cancer survivors predicted to number over 22 million by 2030

by American Cancer SocietyCredit: CC0 Public DomainThere were more than 16.9 million Americans with a history of cancer on January 1, 2019, a number that is projected to reach more than 22.1 mill

Updated on:March 06,2024 20

Researchers use computer modeling to understand how self-renewal processes impact skin cell evolution

by H. Lee Moffitt Cancer Center & Research InstituteThis figure shows snapshots of simulations at three timepoints with cross-sections revealing the mosaic nature of mutations in normal epide

Updated on: February 01,2024 13

Researchers use computer modeling to understand how self-renewal processes impact skin cell evolution

by H. Lee Moffitt Cancer Center & Research InstituteThis figure shows snapshots of simulations at three timepoints with cross-sections revealing the mosaic nature of mutations in normal epide

Updated on:February 01,2024 13

Use of MMR deficiency testing in younger CRC patients is low

(HealthDay)—Fewer than half of younger adults with colorectal cancer (CRC) undergo mismatch repair (MMR) deficiency of DNA testing, according to a study published online Nov. 9 inJAMA Oncology.T

Updated on: April 22,2024 14

Use of MMR deficiency testing in younger CRC patients is low

(HealthDay)—Fewer than half of younger adults with colorectal cancer (CRC) undergo mismatch repair (MMR) deficiency of DNA testing, according to a study published online Nov. 9 inJAMA Oncology.T

Updated on:April 22,2024 14

FDA approves Vyloy for advanced gastric or gastroesophageal junction cancer

by Lori SolomonThe U.S. Food and Drug Administration has approved Vyloy (zolbetuximab-clzb) in combination with fluoropyrimidine- and platinum-containing chemotherapy for the first-line treatment of a

Updated on: November 07,2024 0

FDA approves Vyloy for advanced gastric or gastroesophageal junction cancer

by Lori SolomonThe U.S. Food and Drug Administration has approved Vyloy (zolbetuximab-clzb) in combination with fluoropyrimidine- and platinum-containing chemotherapy for the first-line treatment of a

Updated on:November 07,2024 0

Researchers find new treatment for prostate cancer

by University of Oslo“We think that what we found is really exciting", says Professor Fahri Saatcioglu. Credit: University of OsloProfessor Fahri Saatcioglu at University of Oslo's Depar

Updated on: June 19,2024 4

Researchers find new treatment for prostate cancer

by University of Oslo“We think that what we found is really exciting", says Professor Fahri Saatcioglu. Credit: University of OsloProfessor Fahri Saatcioglu at University of Oslo's Depar

Updated on:June 19,2024 4